These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 6143660

  • 1. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
    Koch BD, Schonbrunn A.
    Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [Abstract] [Full Text] [Related]

  • 4. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
    Presky DH, Schonbrunn A.
    Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
    [Abstract] [Full Text] [Related]

  • 5. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
    Viguerie N, Tahiri-Jouti N, Ayral AM, Cambillau C, Scemama JL, Bastié MJ, Knuhtsen S, Estève JP, Pradayrol L, Susini C.
    Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y, Leiser M, Fleischer N, Erlichman J.
    Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
    [Abstract] [Full Text] [Related]

  • 7. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR, Powell-Jones CH, Thomas CG, Nayfeh SN.
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [Abstract] [Full Text] [Related]

  • 8. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium.
    Koch BD, Dorflinger LJ, Schonbrunn A.
    J Biol Chem; 1985 Oct 25; 260(24):13138-45. PubMed ID: 2865257
    [Abstract] [Full Text] [Related]

  • 9. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R, Prieto JC, Guerrero JM, Goberna R.
    Rev Esp Fisiol; 1981 Mar 25; 37(1):9-16. PubMed ID: 6264553
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium.
    Narayanan N, Lussier B, French M, Moor B, Kraicer J.
    Endocrinology; 1989 Jan 25; 124(1):484-95. PubMed ID: 2562826
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides.
    Perrin MH, Haas Y, Rivier JE, Vale WW.
    Endocrinology; 1986 Mar 25; 118(3):1171-9. PubMed ID: 3004898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of a biotinylated somatostatin analog as a receptor probe.
    Schonbrunn A, Lee AB, Brown PJ.
    Endocrinology; 1993 Jan 25; 132(1):146-54. PubMed ID: 8093437
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 25; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 16. Guanyl nucleotide potentiation of parathyroid hormone-stimulated adenylate cyclase in chicken renal plasma membranes: a receptor-independent effect.
    Nissenson RA, Nyiredy KO, Arnaud CD.
    Endocrinology; 1981 May 25; 108(5):1949-53. PubMed ID: 6260469
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
    Epelbaum J, Enjalbert A, Krantic S, Musset F, Bertrand P, Rasolonjanahary R, Shu C, Kordon C.
    Endocrinology; 1987 Dec 25; 121(6):2177-85. PubMed ID: 2890515
    [Abstract] [Full Text] [Related]

  • 18. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
    Bozou JC, Amar S, Vincent JP, Kitabgi P.
    Mol Pharmacol; 1986 May 25; 29(5):489-96. PubMed ID: 3010077
    [Abstract] [Full Text] [Related]

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 25; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20.
    Mahy N, Woolkalis M, Manning D, Reisine T.
    J Pharmacol Exp Ther; 1988 Oct 25; 247(1):390-6. PubMed ID: 2902214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.